Clinical Outcomes in Parkinson’s with COVID 19 during the’ first wave’ in West Berkshire, United Kingdom (UK)
Objective: To review the outcomes of COVID 19 during the first wave in patients with Parkinson’s in West Berkshire, UK. Background: UK is one of…Long-term cognitive and motor decline across the spectrum of Lewy body disease.
Objective: This study aims to compare the progression of motor and cognitive decline in dementia with Lewy bodies (DLB) compared with Parkinson’s disease (PD) using…Cognitive assessment of Parkinson’s Disease patients in a Northeast Brazilian population: Current Challenges
Objective: To evaluate the influence of education level in the Mini-Mental Status Examination (MMSE) score in Parkinson’s Disease (PD) patients in a northeast Brazilian sample.…Cognitive Impairment in Parkinson’s disease Patients: a Descriptive Study
Objective: This study aims to describe the cognitive profile in Parkinson's disease (PD) patients. Background: Cognitive impairment is a common non-motor symptom of PD. Cohort…Statistical methods for dealing with missing data in longitudinal studies with application to Parkinson’s disease cognition research
Objective: To assess the performance of standard techniques for handling missing data in longitudinal studies under a variety of missing data scenarios. We demonstrate our…α-Synuclein in sympathetic nerve fibers distinguishes PRKN from LRRK2 and other genetic forms of Parkinson’s Disease
Objective: This cross-sectional observational study compared magnitudes of intra-neuronal deposition of α-synuclein in common and rare genetic forms of Parkinson’s disease. Background: Cytoplasmic inclusions of…Lack of diversity in Parkinson’s disease genetic research: current landscape and future directions
Objective: We conducted a systematic review to summarize past studies on Parkinson's disease (PD) genetics research among underrepresented populations (URP), defined as being non-European ancestry. We…MicroRNAs as a potential biomarker of Parkinson’s disease
Objective: Our study was aimed at analyzing the role of microRNA as a potential biomarker of PD. Background: A substantial part of cases of Parkinson’s…VPS35 D620N knockin mice recapitulate cardinal features of Parkinson’s disease
Objective: To establish the pathogenic effects of the PD-causing VPS35 D620N mutation in vivo and address possible underlying mechanisms. Background: D620N mutation in the vacuolar…Changes in brain functional connectivity after cognitive behavioral therapy for anxiety in Parkinson’s disease: a longitudinal MRI study.
Objective: To identify changes in brain functional connectivity (FC) after Cognitive Behavioral Therapy (CBT) for anxiety in patients with Parkinson’s disease (PD). Background: Recently we…
- « Previous Page
- 1
- …
- 419
- 420
- 421
- 422
- 423
- …
- 436
- Next Page »